De la Torre RFE

Idioma: Español
Referencias bibliográficas: 13
Paginas: 244-246
Archivo PDF: 166.00 Kb.

FRAGMENTO

Como en muchas áreas de la medicina el estudio de las enfermedades del tracto genital inferior ha revelado en las últimas décadas mecanismos y fenómenos complejos. Además se ha obtenido claridad en los factores predisponentes y la relación de algunas de las enfermedades comunes con nuestro ambiente.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Steinbrook R. The potential of human papillomavirus vaccines. New Eng J Med 2006;354:1109–1112.

2. Koss LG. The Papanicolaou test for cervical cancer detection. A triumph and a tragedy. JAMA 1989;261:737-43.

3. Bogdanich W. Lax Laboratories: The Pap test misses much cervical cancer through labs’ errors. Wall Street Journal. Nov. 2, 1987:1,20.

4. National Cancer Institute Workshop. The 1988 Bethesda System for reporting cervical/vaginal cytology diagnosis. JAMA 1989;262:931-4.

5. Gibb RK, Martens MG. The impact of liquid-based cytology in decreasing the incidence of cervical cancer. Rev Obstet Gynecol 2011;4(suppl 1);S2-S1.

6. Klaes R, Friedrich T, Spitkovsky D, Ridder R et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001;92:276-84.

7. Klaes R, Benner A, Friedrich T, Ridder R, et al. p16INK4a immunohistochemistry improves inter-observer agreement in the diagnosis of cervical intraepithelial neoplasia, Am J Surg Pathol 2002;26:1389–1399.

8. Aparicio SAJR, Huntsman DG. Does massively prallel DNA resequencing signify the end of histopathology as we know it? J Pathol 2010;220:307-315.

9. Wang SS, Trunk M, Schiffman M, Herrero R, et al. Validation of p16INK4a as a Marker of Oncogenic Human Papillomavirus Infection in Cervical Biopsies from a Population-Based Cohort in Costa Rica. Cancer Epidemiol Biomarkers Prev 2004;13:1355–60.

10. Herrero R, Schiffman MH, Bratti C, Hildesheim A, et a. Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project. Rev Panam Salud Publica 1997;1:362-75.

11. Bratti MC, Rodríguez AC, Schiffman M, Hildesheim A, et al. Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica. Rev Panam Salud Publica 2004;15:75-89.

12. Robles SC, Periago MR. Guanacaste, Costa Rica: a landmark for cervical cancer prevention. Rev Panam Salud Pub 2004;15:73-74.

13. Flores Y, Bishai D, Lazcano E, Shah K, Lörincz A, Hernández M, Salmerón J. Improving cervical cancer screening in Mexico: results from the Morelos HPV Study. Salud Publica Mex 2003;45(Suppl 3):S388-98.